Integra LifeSciences Holdings Corp - Company Profile
Powered by 
All the data and insights you need on Integra LifeSciences Holdings Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Integra LifeSciences Holdings Corp Strategy Report
- Understand Integra LifeSciences Holdings Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Business Description
Integra LifeSciences Holdings Corp (Integra) is a medical technology company, focused on harnesses its engineered collagen-based technology in its varied product lines, which are used in various applications ranging from burns and deep tissue wounds to the repair of nerve and tendon and to repair of dura mater in the brain.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Integra conducts research to advance and improve its product base, and offer new and innovative products. The company conducts R&D to expand its regenerative technology to products for neurosurgical, orthopedic and wound applications with extensive programs in the core platform technologies of orthopedic hardware and electromechanical technologies. It directs its R&D investments in approvals for new indications and next generation improvements to the market-leading products. The company is currently focused on conducting R&D activities related to complex lower extremity reconstruction, diabetic foot ulcers, among others. It is developing new technologies related to collagen xenograft, electromechanical technologies, and ICP monitoring. It incurred R&D expense of US$75.56 million in FY2021, which grew 1.8% YoY. The company operates research facilities in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee and Utah in the US; and Canada, China, France, Germany, Ireland and Switzerland.
Business Segments
Overview
-Offers specialty surgical instrumentation for use in neurosurgery operation suite and critical care unit. -Offers products and solutions for dural access and repair, tissue ablation equipment, advanced energy, cerebrospinal fluid (CSF) management, precision tools and instruments, intracranial monitoring equipment, cranial stabilization equipment and neuro monitoring. -Sells more than 40,000 instrument patterns, precision tools and instruments, and surgical and lighting products. -Serves hospitals, dental, podiatry, surgery centers, and veterinary offices. -Deems that launch of new products is the major factor for growth.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
-Provides regenerative technology products for soft tissue repair, tissue regeneration products, small bone fixation and joint replacement solutions. -Regenerative technology products find application in the treatment of acute and chronic wounds, surgical tissue repairs. -Also offers hardware products such as bone and joint fixation and joint replacement devices, implants and instruments for orthopedic reconstruction of bone in hand, wrist, elbow and shoulder (upper extremity), and foot, ankle and leg below the knee. -Considers continued demand for its skin products and continued relationships with existing private label customers as major factors for growth.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward